Autentificare
NeuroPsy InfoHubÎnțelege · Sprijin · ProgresCere sprijin

Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Începe gratuitSunt părinteSunt specialist
Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

AutismSpectrul autist și particularitățile asociate.223 de articole
ADHDAtenție, impulsivitate și hiperactivitate.202 articole
Sindrom DownDezvoltare și sprijin pentru sindromul Down.57 de articole
AnxietateÎngrijorare excesivă, tensiune, atacuri de panică.73 de articole
DepresieTristețe persistentă, lipsa energiei și a motivației.106 articole
AdicțiiDependențe de substanțe și comportamentale.135 de articole

Afecțiuni neurologice

DemențeBoala Alzheimer și alte forme de demență.73 de articole
AVC și AITAccident vascular cerebral și recuperare, la orice vârstă.64 de articole
Leziuni medulareLeziuni medulare, paraplegie și tetraplegie.55 de articole
EpilepsieCrize epileptice și managementul lor.127 de articole
ParkinsonBoala Parkinson și tulburări de mișcare.64 de articole
Scleroză multiplăScleroza multiplă și viața cu aceasta.71 de articole
Traumatisme cranio-cerebraleTraumatisme cranio-cerebrale și recuperare.81 de articole

Articole și ghiduri recomandate

PublicToțiPentru oricineSpecialiști
VârstăToate vârsteleCopiiTineriAdulțiVârstnici
StudiuDemențeÎncredere bună23.06.2026

Type 2 diabetes mellitus moderates the relationship between interleukin-8 and Alzheimer's disease pathology in mild cognitive impairment

This study analyzed 373 mild cognitive impairment participants to investigate how type 2 diabetes modifies the association between baseline plasma IL-8 levels and cognitive decline, amyloid pathology, and neurodegeneration. Results showed that in the T2DM group, higher IL-8 was associated with slower clinical decline, lower hippocampal amyloid burden, and reduced brain atrophy, suggesting IL-8's role is context-dependent and may reflect an adaptive immune response under metabolic stress.

StudiuDemențeÎncredere bună23.06.2026

D-chiro-inositol Modulates Insulin Signaling and Reduces Amyloid Burden and Neuroinflammation in Preclinical Alzheimer's Disease Models

This preclinical study demonstrates that D-chiro-inositol, a natural compound with insulin-mimetic properties, reduces amyloid-beta production and promotes neuroprotection in cultured neurons and transgenic mouse models of Alzheimer's disease. The compound enhances insulin receptor signaling, modulates tau-related kinase activity, and shifts immune responses in the brain toward less inflammatory states, suggesting potential therapeutic mechanisms worth further investigation.

StudiuDemențeÎncredere înaltă23.06.2026

Unawareness of Deficits in Mild Cognitive Impairment: A Systematic Review of Its Role in Progression to Alzheimer's Disease

This systematic review examines whether reduced awareness of cognitive decline in individuals with mild cognitive impairment (MCI) serves as a predictor of conversion to Alzheimer's disease or dementia. The study synthesized evidence from 11 peer-reviewed longitudinal studies across major databases to clarify whether diminished insight into cognitive abilities in early stages could identify at-risk individuals who need timely intervention.

StudiuDemențeÎncredere bună23.06.2026

Sex Differences in Adverse Childhood Experiences and Brain Structure/Cognition Along the Alzheimer's Disease Continuum

This study investigates why women develop Alzheimer's disease at higher rates by examining how adverse childhood experiences (ACEs) affect brain structure and cognitive function differently in men versus women across stages of cognitive decline. Results show women reported more ACEs, and these experiences were associated with reduced brain volumes in cognitively unimpaired men and memory/executive function deficits in women with mild cognitive impairment, suggesting psychosocial factors may contribute to sex differences in dementia risk.

StudiuDemențeÎncredere înaltă23.06.2026

Digital Speech-Based Markers to Advance Prognosis in Alzheimer's Disease

Speech-based digital markers offer a scalable, non-invasive approach to predicting cognitive decline and complementing blood biomarkers in Alzheimer's disease, though large multilingual longitudinal datasets are lacking. The SpeechDx study is a 3-year multinational observational research program (n=2006) designed to develop and validate speech-based tools for early risk assessment and personalized intervention in preclinical populations.